HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard A. Hopkins Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hilbert, S. L. Articles by Ferrans, V. J. Search for Related Content PubMed PubMed Citation Articles by Hilbert, S. L. Articles by Ferrans, V. J.

J Thorac Cardiovasc Surg 1999;117:454-462
© 1999 Mosby, Inc.

SURGERY FOR ADULT CARDIOVASCULAR DISEASE

ALLOGRAFT HEART VALVES: THE ROLE OF APOPTOSIS-MEDIATED CELL LOSS

From the Center for Devices and Radiographical Health, Food and Drug Administration, Rockville, Md; the Pathology Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md; the Department of Surgery, Georgetown University Medical Center, Washington, DC; and the Department of Surgery, Brown University, School of Medicine, Providence, RI.

The opinions or assertions are the private views of the authors and are not to be construed as conveying either an official endorsement or criticism by the US Department of Health and Human Services, the Food and Drug Administration, or the National Institutes of Health.

Received for publication May 6, 1998. Revisions requested July 10, 1998. Revisions received Oct 5, 1998. Accepted for publication Oct 7, 1998. Address for reprints: Stephen L. Hilbert, MD, PhD (HFZ-150), Center for Devices and Radiological Health, Food and Drug Administration, 9200 Corporate Blvd, Rockville, MD 20850.

Objective: The purpose of this study was to determine whether apoptosis of endothelial and connective tissue cells is responsible for the loss of cellularity observed in implanted aortic allograft valves.
Methods: Fresh (n = 6) and cryopreserved (n = 4) aortic allograft valves were retrieved at 2 days to 20 weeks after implantation in an ovine model. Sections of these valves were studied with the use of histologic and electron microscopic methods, nick end–labeling and dual immunostaining for factor VIII–related antigen and proliferating cell nuclear antigen, followed by counterstaining for DNA and laser scanning confocal fluorescence microscopic observation.
Results: The endothelial cells and cusp connective tissue cells of implanted valvular allografts showed loss of proliferating cell nuclear antigen (indicative of cessation of mitotic activity) and evidence of apoptosis (nick end labeling). The latter was manifested by nuclear condensation and pyknosis, positive nick end labeling, and formation of intra- and extracellular apoptotic bodies derived from the fragmentation of apoptotic cells. These changes began to develop at 2 days after implantation, peaking at 10 to 14 days, and became complete by 20 weeks, at which time the valves had the typical acellular morphologic features of allografts implanted for long periods of time.
Conclusions: Apoptosis occurs in endothelial cells and cuspal connective tissue cells of implanted allografts and appears to be a cause of their loss of cellularity. This apoptosis may be related to various factors, including immunologic and chemical injury, and hypoxia during valve processing and reperfusion injury at the time of implantation.

This article has been cited by other articles:

				H. J. Geissler, U. M. Fischer, S. Foerster, A. Krahwinkel, A. Antonyan, A. Kroener, K. Addicks, U. Mehlhorn, and W. Bloch Effect of Thawing on Nitric Oxide Synthase III and Apoptotic Markers in Cryopreserved Human Allografts Ann. Thorac. Surg., November 1, 2006; 82(5): 1742 - 1746. [Abstract] [Full Text] [PDF]

				R. A. Hopkins Bioprosthetic Valves and Laudable Inflammation? Circulation, July 25, 2006; 114(4): 261 - 264. [Full Text] [PDF]

				F. Sayk, I. Bos, U. Schubert, T. Wedel, and H.-H. Sievers Histopathologic Findings in a Novel Decellularized Pulmonary Homograft: An Autopsy Study Ann. Thorac. Surg., May 1, 2005; 79(5): 1755 - 1758. [Abstract] [Full Text] [PDF]

				A. Ketchedjian, A. L. Jones, P. Krueger, E. Robinson, K. Crouch, L. Wolfinbarger Jr, and R. Hopkins Recellularization of Decellularized Allograft Scaffolds in Ovine Great Vessel Reconstructions Ann. Thorac. Surg., March 1, 2005; 79(3): 888 - 896. [Abstract] [Full Text] [PDF]

				R. W. Grauss, M. G. Hazekamp, S. van Vliet, A. C. Gittenberger-de Groot, and M. C. DeRuiter Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2003 - 2010. [Abstract] [Full Text] [PDF]

				D. R. Koolbergen, M. G. Hazekamp, E. de Heer, E. F. Bruggemans, H. A. Huysmans, R. A. E. Dion, and J. A. Bruijn The pathology of fresh and cryopreserved homograft heart valves: An analysis of forty explanted homograft valves J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 689 - 697. [Abstract] [Full Text] [PDF]

				J.-F. Legare, D. B. Ross, T. B. Issekutz, W. Ruigrok, K. Creaser, G. M. Hirsch, and T. D.G. Lee Prevention of allograft heart valve failure in a rat model J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 310 - 317. [Abstract] [Full Text] [PDF]

				J.-F. Legare, M. A. Nanton, P. Bryan, T. D. G. Lee, and D. B. Ross Aortic valve graft implantation in rats: a new functional model J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 679 - 685. [Abstract] [Full Text] [PDF]

				J. F. Legare, T. D.G. Lee, K. Creaser, and D. B. Ross T lymphocytes mediate leaflet destruction and allograft aortic valve failure in rats Ann. Thorac. Surg., October 1, 2000; 70(4): 1238 - 1245. [Abstract] [Full Text] [PDF]